Keeping a portion of your portfolio dedicated to stocks of solid, dividend-paying companies is a wise strategy for building wealth for the long term while maintaining some relative safety. Stocks of large pharmaceutical companies come into favor in times of economic uncertainty because of their ability to maintain margins and typically healthy cash flows during downturns. Does pharmaceutical giant Merck (NYSE: MRK) merit a spot in a conservative dividend portfolio?